Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Ixchiq® (Chikungunya vaccine, live) – FDA removes pause in use in patients 60 years and older

August 6, 2025 - The FDA removed the recommended pause in the use of Ixchiq (Chikungunya vaccine, live) in individuals 60 years of age and older and has approved updates to the prescribing information and patient information.

Download PDF

Rx navigation